DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients

AIM: This study examined catechol-O-methyltransferase (COMT) DNA methylation in the peripheral blood of schizophrenia patients and also in healthy controls to investigate its potential use as a peripheral biomarker of schizophrenia and its relations with the clinical variables of schizophrenia pa...

Full description

Bibliographic Details
Main Authors: Abd Rahim, Nour El Huda, Ku Zaifah, Norsidah, Mohd Rahim, Nabil Fikri, Mohd Noor, Hanisah, Abdullah, Kartini, A.Talib, Norlelawati
Format: Article
Language:English
English
English
Published: Blackwell Publishing 2018
Subjects:
Online Access:http://irep.iium.edu.my/63786/
http://irep.iium.edu.my/63786/12/63786_DNA%20methylation%20of%20membrane-bound%20catechol-O-methyltransferase_scopus.pdf
http://irep.iium.edu.my/63786/35/63786%20DNA%20methylation%20of%20membrane-bound%20catechol-O-methyltransferase%20in%20Malaysian%20schizophrenia%20patients_wos.pdf
http://irep.iium.edu.my/63786/41/63786_DNA%20methylation%20of%20membrane-bound.pdf
_version_ 1848786093671972864
author Abd Rahim, Nour El Huda
Ku Zaifah, Norsidah
Mohd Rahim, Nabil Fikri
Mohd Noor, Hanisah
Abdullah, Kartini
A.Talib, Norlelawati
author_facet Abd Rahim, Nour El Huda
Ku Zaifah, Norsidah
Mohd Rahim, Nabil Fikri
Mohd Noor, Hanisah
Abdullah, Kartini
A.Talib, Norlelawati
author_sort Abd Rahim, Nour El Huda
building IIUM Repository
collection Online Access
description AIM: This study examined catechol-O-methyltransferase (COMT) DNA methylation in the peripheral blood of schizophrenia patients and also in healthy controls to investigate its potential use as a peripheral biomarker of schizophrenia and its relations with the clinical variables of schizophrenia patients. METHODS: We examined the DNA methylation levels of COMT using genomic DNA from the peripheral blood of schizophrenia patients (n = 138) and healthy control participants (n = 132); all were Malaysian Malays. The extracted DNA was bisulfite converted, and the percentage methylation ratio value was calculated based on the results following a MethyLight protocol analysis. RESULTS: The percentage methylation ratio of COMT was lower in schizophrenia than it was in the healthy controls (P < 0.001) and was different between the body mass index (P = 0.003) and antipsychotic (P = 0.004) groups. The COMT DNA methylation rate was lower in patients receiving atypical antipsychotics (P = 0.004) and risperidone (P = 0.049) as compared to typical antipsychotics. The Excitement and Depressed subdomains of the Positive and Negative Syndrome Scale were inversely related (P < 0.001) and therefore predictors (Excitement: b = -11.396, t = -4.760, P < 0.001; Depressed: b = -7.789, t = -3.487, P = 0.001) of COMT DNA methylation. CONCLUSION: Our results suggested that the methylation level was affected by the severity of the clinical symptoms of schizophrenia and might also be influenced by pharmacological treatment. The epigenetic alteration of COMT in the peripheral blood could be a potential peripheral biomarker of schizophrenia.
first_indexed 2025-11-14T17:03:33Z
format Article
id iium-63786
institution International Islamic University Malaysia
institution_category Local University
language English
English
English
last_indexed 2025-11-14T17:03:33Z
publishDate 2018
publisher Blackwell Publishing
recordtype eprints
repository_type Digital Repository
spelling iium-637862022-01-24T04:03:15Z http://irep.iium.edu.my/63786/ DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients Abd Rahim, Nour El Huda Ku Zaifah, Norsidah Mohd Rahim, Nabil Fikri Mohd Noor, Hanisah Abdullah, Kartini A.Talib, Norlelawati RM Therapeutics. Pharmacology AIM: This study examined catechol-O-methyltransferase (COMT) DNA methylation in the peripheral blood of schizophrenia patients and also in healthy controls to investigate its potential use as a peripheral biomarker of schizophrenia and its relations with the clinical variables of schizophrenia patients. METHODS: We examined the DNA methylation levels of COMT using genomic DNA from the peripheral blood of schizophrenia patients (n = 138) and healthy control participants (n = 132); all were Malaysian Malays. The extracted DNA was bisulfite converted, and the percentage methylation ratio value was calculated based on the results following a MethyLight protocol analysis. RESULTS: The percentage methylation ratio of COMT was lower in schizophrenia than it was in the healthy controls (P < 0.001) and was different between the body mass index (P = 0.003) and antipsychotic (P = 0.004) groups. The COMT DNA methylation rate was lower in patients receiving atypical antipsychotics (P = 0.004) and risperidone (P = 0.049) as compared to typical antipsychotics. The Excitement and Depressed subdomains of the Positive and Negative Syndrome Scale were inversely related (P < 0.001) and therefore predictors (Excitement: b = -11.396, t = -4.760, P < 0.001; Depressed: b = -7.789, t = -3.487, P = 0.001) of COMT DNA methylation. CONCLUSION: Our results suggested that the methylation level was affected by the severity of the clinical symptoms of schizophrenia and might also be influenced by pharmacological treatment. The epigenetic alteration of COMT in the peripheral blood could be a potential peripheral biomarker of schizophrenia. Blackwell Publishing 2018-04 Article PeerReviewed application/pdf en http://irep.iium.edu.my/63786/12/63786_DNA%20methylation%20of%20membrane-bound%20catechol-O-methyltransferase_scopus.pdf application/pdf en http://irep.iium.edu.my/63786/35/63786%20DNA%20methylation%20of%20membrane-bound%20catechol-O-methyltransferase%20in%20Malaysian%20schizophrenia%20patients_wos.pdf application/pdf en http://irep.iium.edu.my/63786/41/63786_DNA%20methylation%20of%20membrane-bound.pdf Abd Rahim, Nour El Huda and Ku Zaifah, Norsidah and Mohd Rahim, Nabil Fikri and Mohd Noor, Hanisah and Abdullah, Kartini and A.Talib, Norlelawati (2018) DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients. Psychiatry and Clinical Neuroscience, 72 (4). pp. 266-279. ISSN 1323-1316 E-ISSN 1440-1819 https://onlinelibrary.wiley.com/journal/14401819 10.1111/pcn.12622
spellingShingle RM Therapeutics. Pharmacology
Abd Rahim, Nour El Huda
Ku Zaifah, Norsidah
Mohd Rahim, Nabil Fikri
Mohd Noor, Hanisah
Abdullah, Kartini
A.Talib, Norlelawati
DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients
title DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients
title_full DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients
title_fullStr DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients
title_full_unstemmed DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients
title_short DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients
title_sort dna methylation of membrane-bound catechol-o-methyltransferase in malaysian schizophrenia patients
topic RM Therapeutics. Pharmacology
url http://irep.iium.edu.my/63786/
http://irep.iium.edu.my/63786/
http://irep.iium.edu.my/63786/
http://irep.iium.edu.my/63786/12/63786_DNA%20methylation%20of%20membrane-bound%20catechol-O-methyltransferase_scopus.pdf
http://irep.iium.edu.my/63786/35/63786%20DNA%20methylation%20of%20membrane-bound%20catechol-O-methyltransferase%20in%20Malaysian%20schizophrenia%20patients_wos.pdf
http://irep.iium.edu.my/63786/41/63786_DNA%20methylation%20of%20membrane-bound.pdf